Pharmacogenetics of drug-induced liver injury-Reference-Cited by-同舟云学术

Pharmacogenetics of drug-induced liver injury

Published:2010-04-19 Issue:2 Volume:52 Page:748-761
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Russmann Stefan,Jetter Alexander,Kullak-Ublick Gerd A.

Publisher

Wiley

Subject

Hepatology

Reference108 articles.

1. HLA-B*5701 screening for hypersensitivity to abacavir;Mallal;N Engl J Med,2008

2. A review of epidemiologic research on drug-induced acute liver injury using the general practice research database in the United Kingdom;Garcia Rodriguez;Pharmacotherapy,1997

3. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database;Russmann;Br J Clin Pharmacol,2005

4. Incidence of drug-induced hepatic injuries: a French population-based study;Sgro;HEPATOLOGY,2002

5. The role of metabolic activation in drug-induced hepatotoxicity;Park;Annu Rev Pharmacol Toxicol,2005

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs);Drug Metabolism Reviews;2024-08-09

2. Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies;Molecules;2024-06-04

3. Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations;Liver International;2024-03-07

4. Inhibition of 15-prostaglandin dehydrogenase attenuates acetaminophen-induced liver injury via suppression of apoptosis in liver endothelial cells;Prostaglandins, Leukotrienes and Essential Fatty Acids;2024-03

5. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox;Biochemical Pharmacology;2023-03